Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Category: Conferences
-
Informa Life Sciences will be holding its 17th annual "EU Pharmaceutical Law Forum" in Brussels, Belgium, on May 8 and 9. This conference is billed as the "must attend" meeting for in-house counsel in pharmaceutical companies and lawyers in private practice who specialize in the life sciences. Speakers will examine in detail the recent developments…
-
Legal IQ, a division of IQPC, will be holding a highly interactive two-day conference, "Optimising Pharmaceutical Patent Lifecycles," in London, April 29-30. The conference will focus on how to maximize product revenues and yet avoid anti-competitive issues through strategic patent lifecycle management. Featuring seventeen international experts, the conference will cover hot topics such as how…
-
Informa Life Sciences will hold its 7th annual "Global Generics Strategy Summit" conference in Barcelona, Spain, March 4-5, 2008. The conference "represents the largest gathering of Generics leaders from across the globe and will explore new and emerging strategies and regulations that must be followed to remain competitive in this cut-throat industry." The conference features…
-
IQPC will be holding its 3rd annual "Pharmaceutical Patent Litigation Strategies" conference in London, March 31 to April 1. The conference is split into two days–one focusing on European law, the other focusing on U.S. law–and includes an optional third day, with workshops. The European Focus Day will emphasize proposals for supranational patent litigation; EPLA;…
-
American Conference Institute will hold its fifth annual “Pharma/Biotech IP Due Diligence” conference January 30-31 in New York. ACI describes this conference as the “complete guide for M&As, licensing and other collaborations.” The agenda includes several talks that sound especially interesting, including: “Factoring Patent Reform, PTO Rulemaking and New Case Law Into Your Due Diligence…
-
The International Institute for Business Information & Growth will hold a conference entitled “New Directions for Drug Delivery,” October 29-30 in Las Vegas, Nevada. The conference is designed for pharmaceutical scientists and specialty pharma, biopharmaceutical, and nanotechnology licensing and business development team leaders. According to iiBIG, attendees will learn “how new scientific technologies are driving investments,…
-
American Conference Institute will hold its eighth annual "Maximizing Pharmaceutical Patent Life Cycles" conference October 24-25 in New York. According to ACI, this is the "one and only event that has consistently allowed brand name and generic drug makers to benchmark their companies’ current strategies and tactics against competitors in both camps." The agenda includes…
-
The Federal Circuit reissued its July 11 opinion in Daiichi Sankyo v. Apotex as a precedential opinion, one day after denying Daiichi's petition for rehearing. According to Hal Wegner, a major reason for making the decision precedential was Prof. Joseph Scott Miller's Rule 47.6(c) filing. Biosimilars legislation is "off the table" for now. The FDA…
-
The Institute for International Research will be holding its 8th annual “Generic Drugs Summit” at the Fairmont Hotel in Washington, D.C., September 17-19. According to IIR, this is “the leading independent forum for addressing business and legal concerns impacting the Generics marketplace.” The conference features three pre-event symposia and workshops on September 17: Full day:…
-
American Conference Institute will be holding its Pharma/Biotech Patent Boot Camp conference in San Francisco, September 18-19. According to ACI, the conference “has been designed to give new patent attorneys and patent attorneys who are new to the life sciences industries–as well as business executives in pharma and biotech companies–a strong working knowledge of essential…
